Dedicated to the application of biocatalysis ChiralVision was founded in 2006, privately funded with headquarters now in the Delft area situated between the major towns of Rotterdam and Den Hague, The Netherlands
Some "historic" highlights:
2006 - Founding of ChiralVision in Leiden, the Netherlands
2006 - Introduction of first Immozymes and chiral products
2006 - 1st patented custom API process
2007 - Collaboration with Genencor International
2008 - Products available via Sigma-Aldrich
2008 - 1st Immozyme in API production process
2009 - Over 100 immobilized enzyme products
2010 - Over 60 unique chiral compounds in portfolio
2010 - Food & Nutrition Delta funding for "healthy fats"
2012 - EU funding for clean water research (Endetech)
2013 - EU project for phosphate recycling (Phosfarm)
2015 - Collaboration with Nordic Chemquest (now SpinChem) for SpinChem reactor development
2016 - Eurostars funding for biocide replacement (Bio-Attract).
2016 - ERA-IB (Industrial Biotechnology) project “No P” for enzymatic sugar coupling reactions.
2019 - Move into new and larger facilities in Den Hoorn, the Netherlands
2019 - MACBETH project: Membranes And Catalysts Beyond Economic and Technological Hurdles. Budget: 20,7 M€
ChiralVision develops biocatalysis based technologies and solutions. We can help you to develop new and proprietary solutions in various markets, or take your existing technology and develop a scalable process.
We are a supplier of off-shelf (immobilized) enzymes, enzyme carriers, chiral molecules, custom products, technology subcontractor or collaborator in a joint development effort.
To discuss your interest please email or phone us:
Tel: +31 085 068 5558
"Leloir Glycosyltransferases in Applied Biocatalysis: A Multidisciplinary Approach", Mestrom et al; Int. J. Mol. Sci. 2019, 20(21), 5263
"Removal of Endocrine Disrupting Chemicals in Wastewater by Enzymatic Treatment with Fungal Laccases"; Becker et al; Org. Process Res. Dev., 2017, 21 (4), pp 480–491
"Removal of antibiotics in wastewater by enzymatic treatment with fungal laccase - Degradation of compounds does not always eliminate toxicity." Becker et al; Bioresour Technol 2016 Nov 4;219:500-509. Epub 2016 Aug 4.
"Cleaning Up Drugs In Wastewater", August 3, 2015 Issue - Vol. 93 Issue 31 _ Chemical & Engineering News
"Macroporous beads for enzyme immobilization with high activity retention"
Pharmachem, September/October 2010, p 11.
"Immobilized Bulk Enzymes Catalysts for Chiral Intermediate and Chiral API Production"
CHEManager Europe, June 2009, page 9.
"Immobilized bulk proteases in enzymatic resolution. Production of non-natural amino acids with high chiral purity"
Pharmachem, April/May 2009, p 10.